Core Insights - Hims and Hers Health Inc (NYSE:HIMS) shows strong performance when its stock crosses above the 50-day moving average, with an average next-month return of 31.8% and an 83% win rate [1] - The company is expanding its treatment offerings beyond weight-loss drugs, particularly into low-testosterone treatments, which has been positively received by the market [1] - There is a significant short interest in HIMS, with 38% of the stock's total float sold short, indicating potential for a short squeeze and additional upward momentum [2] Technical Analysis - The stock has experienced pullbacks to its 12-month moving average, creating favorable buying opportunities [1] - Options support is concentrated at the $50 level, where peak call open interest is located, suggesting a strategic point for options trading [4] - Implied volatilities are currently lower than 85% of daily readings over the past year, indicating a favorable environment for purchasing options [4] Investment Strategy - A recommended December call option has a leverage ratio of 2.9, which could double with a 36.6% rise in the underlying stock [5]
Telehealth Stock Looks Primed for a Short Squeeze